The University of Chicago Header Logo

Connection

Ernst Robert Lengyel to Promoter Regions, Genetic

This is a "connection" page, showing publications Ernst Robert Lengyel has written about Promoter Regions, Genetic.
  1. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J Biol Chem. 1995 Sep 29; 270(39):23007-12.
    View in: PubMed
    Score: 0.106
  2. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors. Biochim Biophys Acta. 1995 Jul 20; 1268(1):65-72.
    View in: PubMed
    Score: 0.104
  3. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers. Clin Cancer Res. 2003 Jun; 9(6):2267-76.
    View in: PubMed
    Score: 0.045
  4. Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2. Endocrinology. 2001 Aug; 142(8):3663-72.
    View in: PubMed
    Score: 0.040
  5. Ras regulation of urokinase-type plasminogen activator. Methods Enzymol. 2001; 333:105-16.
    View in: PubMed
    Score: 0.038
  6. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression. J Invest Dermatol. 1999 Jul; 113(1):69-76.
    View in: PubMed
    Score: 0.034
  7. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. J Biol Chem. 1999 Jun 04; 274(23):16377-86.
    View in: PubMed
    Score: 0.034
  8. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line. J Cell Biochem. 1996 Jun 01; 61(3):430-43.
    View in: PubMed
    Score: 0.028
  9. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem. 1996 May 03; 271(18):10672-80.
    View in: PubMed
    Score: 0.028
  10. Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015 May 28; 521(7553):489-94.
    View in: PubMed
    Score: 0.026
  11. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer. Mol Cancer Res. 2007 May; 5(5):485-96.
    View in: PubMed
    Score: 0.015
  12. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers. Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8538-48.
    View in: PubMed
    Score: 0.013
  13. Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor. J Cell Sci. 2002 Oct 15; 115(Pt 20):3879-88.
    View in: PubMed
    Score: 0.011
  14. beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter. Mol Cell Biol. 2001 Mar; 21(6):2118-32.
    View in: PubMed
    Score: 0.010
  15. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene. 1997 Mar 27; 14(12):1481-93.
    View in: PubMed
    Score: 0.007
  16. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. Anticancer Res. 1995 Jul-Aug; 15(4):1167-72.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.